- Research works
- 73 ▲ 334% vs 2013–17
- Citations
- 1.5k 19.9 per fractional work
- Top-10% rate
- 17.8% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Tango Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Tango Therapeutics (United States) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 18.6× the share of its output that it takes of world research.
- Molecular BiologySubfield · 22.4 works19×
- Biochemistry, Genetics and Molecular BiologyField · 24.3 works11×
- Life SciencesDomain · 28.7 works5.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 11.4×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 11.4×
- Immunology and Microbiology 6.1×
- Chemistry 1.6×
- Neuroscience 1.4×
- Medicine 1.0×
- Agricultural and Biological Sciences 0.6×
- Environmental Science 0.4×
- Earth and Planetary Sciences 0.3×
- Social Sciences 0.1×
- Health Professions 0.1×
- Engineering 0.1×
- Psychology 0.1×
- Computer Science 0.1×
Who are the top researchers at Tango Therapeutics (United States)?
Ranked on the composite score, Jannik N. Andersen, William D. Mallender and Alan Huang lead among researchers whose main affiliation is Tango Therapeutics (United States).
- 1 Jannik N. Andersen United States · #711,560 worldwide 69 citations · 30 works
- 2 William D. Mallender United States · #962,448 worldwide 56 citations · 18 works
- 3 Alan Huang United States · #1,537,909 worldwide 7 citations · 27 works
Which keywords describe research at Tango Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Cell Proliferation, Epigenetic Regulation, Arginine Methylation, Protein Arginine Methyltransferases, Cancer Therapy and Tumor Microenvironment.
- Immunotherapy
- Proteasome
- Glycosylation
- Nanoparticles
- RNA-Guided
- Genome Engineering
- Homologous Recombination
- Fibroblast Activation Protein
- Angiogenesis
- Tumor Microenvironment
- Protein Arginine Methyltransferases
- Epigenetic Regulation
- Transcriptional Regulation
- Cancer
- Cell Proliferation
- Arginine Methylation
- Cancer Therapy
- Cell Death
- Cancer Immunotherapy
- Immunosuppression
- Gene Expression
- Inflammation
- BRCA Mutation
- PARP Inhibitors
- Medicinal Chemistry
- Ubiquitin
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Cancer17▲ 32×11 topics
- Transcriptional Regulation15▲ 240×4 topics
- Cell Proliferation15▲ 433×3 topics
- Epigenetic Regulation15▲ 170×2 topics
- Arginine Methylation14▲ 1316×1 topic
- Protein Arginine Methyltransferases14▲ 1316×1 topic
- Cancer Therapy5▲ 22×8 topics
- Tumor Microenvironment4▲ 20×6 topics
- Cell Death2▲ 21×3 topics
- Angiogenesis2▲ 14×2 topics
- Cancer Immunotherapy2▲ 30×3 topics
- Fibroblast Activation Protein2▲ 105×1 topic
- Immunosuppression2▲ 51×1 topic
- Homologous Recombination2▲ 93×2 topics
- Gene Expression2▲ 6.0×4 topics
- Genome Engineering1▲ 52×1 topic
- Inflammation1▲ 1.57×9 topics
- RNA-Guided1▲ 52×1 topic
- BRCA Mutation1▲ 136×1 topic
- Nanoparticles1▲ 2.4×3 topics
- PARP Inhibitors1▲ 136×1 topic
- Glycosylation1▲ 24×2 topics
- Medicinal Chemistry1▲ 10.0×3 topics
- Proteasome1▲ 76×1 topic
- Ubiquitin1▲ 76×1 topic
- Immunotherapy1▲ 3.6×4 topics
Which research topics does Tango Therapeutics (United States) publish most on?
By volume in 2022–2025: Cancer-related gene regulation, Peptidase Inhibition and Analysis, CRISPR and Genetic Engineering and PARP inhibition in cancer therapy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer-related gene regulation Molecular Biology 14 works
- 2 Peptidase Inhibition and Analysis Oncology 2 works
- 3 CRISPR and Genetic Engineering Molecular Biology 1 works
- 4 PARP inhibition in cancer therapy Oncology 1 works
- 5 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 6 CAR-T cell therapy research Oncology 1 works
- 7 Phagocytosis and Immune Regulation Immunology 1 works
- 8 Synthesis and Catalytic Reactions Organic Chemistry 1 works
- 9 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 1 works
- 10 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tango Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 334% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.